/Bristol-Myers%20Squibb%20Co_%20logo%20on%20building-by%20tatu%20Campelo%20via%20iStock.jpg)
Bristol-Myers Squibb Company (BMY) is one of the leading biopharmaceutical companies focused on developing treatments for cancer, inflammatory, immunologic, cardiovascular and fibrotic diseases. With a market cap of $119.8 billion, Bristol-Myers’ operations span various countries in the Americas, Europe, and the Indo-Pacific.
The Princeton, New Jersey-based pharma giant has slightly lagged behind the S&P 500 over the past year. BMY has gained 19.7% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 23.3% surge during the same time frame. However, BMY has soared 4.6% on a YTD basis outpacing SPX’s 2.6% gains in 2025.